Department of Psychological and Brain Sciences, Boston University , Boston, MA.
Psychiatry and Behavioral Sciences, Duke University Medical Center , Durham, NC.
Behav Sleep Med. 2020 Jul-Aug;18(4):560-569. doi: 10.1080/15402002.2019.1629445. Epub 2019 Jun 14.
OBJECTIVES/BACKGROUND: Disruptions to mood, cognition, and other daytime functioning are common and debilitating symptoms of Parkinson's disease (PD), and there is evidence that sleep problems contribute to these symptoms. However, previous studies are limited by reliance on self-reported sleep and cross-sectional designs. With the aim of assessing sleep as a possible treatment target for improving daytime functioning in PD, we used smartphone-based ecological momentary assessment (EMA) and actigraphy to investigate temporal associations between sleep (objective and subjective) and daytime functioning.
PARTICIPANTS/METHODS: Twenty participants with mild-moderate PD wore actigraphs and completed sleep diaries for 14-15 days. They reported daytime functioning (anxiety, positive affect, cognitive function, fatigue, and social function) twice daily via smartphone-administered questionnaires. Multilevel modeling examined whether sleep quantity/quality predicted next-day functioning, and whether current mood (anxiety, positive affect) predicted later sleep.
Average completion rates for sleep diaries and daytime questionnaires were 94% and 91%, respectively. Subjective sleep quality predicted next-day anxiety (B = -.75, SE = .25, = .003), but objective sleep did not predict any daytime functioning variables ('s>.112). Positive affect predicted later subjective sleep quality (B = 0.03, SE = .01, = .003) but not objective sleep quantity/quality ('s>.107).
We demonstrated the feasibility of using EMA in PD. On a daily timescale, subjective sleep quality was bidirectionally associated with mood, whereas objective sleep was not associated with any daytime functioning. This discrepancy suggests that of sleep is important for mood in PD, which could provide targets for non-pharmacological interventions.
目的/背景:情绪、认知和其他日间功能障碍是帕金森病(PD)的常见且使人虚弱的症状,有证据表明睡眠问题对此类症状有影响。然而,先前的研究受到对自我报告的睡眠和横断面设计的依赖的限制。为了评估睡眠作为改善 PD 日间功能的可能治疗目标,我们使用基于智能手机的生态瞬时评估(EMA)和活动记录仪来研究睡眠(客观和主观)与日间功能之间的时间关联。
参与者/方法:20 名轻度至中度 PD 患者佩戴活动记录仪并完成了 14-15 天的睡眠日记。他们通过智能手机管理的问卷每天两次报告日间功能(焦虑、积极情绪、认知功能、疲劳和社会功能)。多层次模型检验了睡眠量/质是否预测次日的功能,以及当前的情绪(焦虑、积极情绪)是否预测以后的睡眠。
睡眠日记和日间问卷的平均完成率分别为 94%和 91%。主观睡眠质量预测次日的焦虑(B=-.75,SE=.25,=0.003),但客观睡眠不能预测任何日间功能变量(>.112)。积极情绪预测以后的主观睡眠质量(B=0.03,SE=.01,=0.003),但不预测客观睡眠的数量/质量(>.107)。
我们证明了 EMA 在 PD 中的可行性。在每日时间尺度上,主观睡眠质量与情绪呈双向关联,而客观睡眠与任何日间功能均无关联。这种差异表明,PD 中的睡眠主观体验对于情绪很重要,这可能为非药物干预提供了目标。